Inequalities in outcomes for non-small cell lung cancer: The influence of clinical characteristics and features of the local lung cancer service

Thorax

Volumn 66, Issue 12, 2011, Pages 1078-1084

  Rich, Anna L ^a   Tata, Laila J ^a   Free, Catherine M ^b   Stanley, Rosamund A ^c   Peake, Michael D ^b   Baldwin, David R ^d   Hubbard, Richard B ^a,e  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c NATIONAL HEALTH SERVICE   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; COMORBIDITY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; THORAX SURGERY; UNITED KINGDOM;

EID: 81555209705     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2011.158972     Document Type: Article

References (30)

1. Socinski MA, Crowell R, Hensing TE, et al. Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 Suppl):277-89S.
2. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 1999;86:1867-76. (Pubitemid 29513058)
3. Chansky K, Sculier JP, Crowley JJ, et al. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 2009;4:792-801.
4. National Institute for Clinical Excellence (NICE). The Diagnosis and Treatment of Lung Cancer. London: NICE, 2005.
5. Crook A, Duffy A, Girling DJ, et al. Survey on the treatment of non-small cell lung cancer (NSCLC) in England and Wales. Eur Respir J 1997;10:1552-8. (Pubitemid 27311071)
6. Ries LA, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1975-2002. National Cancer Institute (USA), 2005.
7. Department of Health. Cancer Reform Strategy; Achieving Local ImplementationdSecond Annual Report. London: Department of Health, 2009.
8. Damhuis RA, Schutte PR. Resection rates and postoperative mortality in 7,899 patients with lung cancer. Eur Respir J 1996;9:7-10. (Pubitemid 26037523)
9. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
10. Rich AL, Tata LJ, Stanley RA, et al. Lung cancer in England: information from the National Lung Cancer Audit (LUCADA). Lung Cancer 2011;72:16-22.
11. National Lung Cancer Audit. Annual Report 2008. The NHS Information Centre for Health and Social Care, 2009. http://www.ic.nhs.uk/webfiles/Services/ NCASP/audits %20and%20reports/NHS%20IC%20Lung%20Cancer%20AUDIT%202009%20FINAL. pdf.
12. National Lung Cancer Audit. Key Findings about the Quality of Care for People with Lung Cancer in England and Wales Incorporating Headline and Completeness Data from Scotland. Report for the Audit Period 2007. The NHS Information Centre for Health and Social Care, 2008. http://www.ic.nhs.uk/ webfiles/Services/NCASP/audits %20and%20reports/7089-Lung-Cancer-V5.pdf.
13. National Lung Cancer Audit. Annual Report 2006. The NHS Information Centre for Health and Social Care, 2007. http://www.ic.nhs.uk/webfiles/Services/ NCASP/audits %20and%20reports/19100507%20IC%20Lung%20Cancer%20Audit%20Report% 202006-FV.pdf.
14. Khan NF, Perera R, Harper S, et al. Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract 2010;11:1.
15. Wang CY, Lin YS, Tzao C, et al. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection. Eur J Cardiothorac Surg 2007;32:877-81. (Pubitemid 350064558)
16. Asmis TR, Ding K, Seymour L, et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 2008;26:54-9.
17. National Cancer Institute. National Lung Screening Trial Results: Fast Facts. 2011. http://www.cancer.gov/newscenter/pressreleases/2011/NLSTFastFacts.
18. Cronin-Fenton DP, Norgaard M, Jacobsen J, et al. Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer 2007;96:1462-8. (Pubitemid 46685783)
19. Wildes TM, Augustin KM, Sempek D, et al. Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2008;14:840-6. (Pubitemid 351773161)
20. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245-51.s (Pubitemid 24361532)
21. Dalton SO, Steding-Jessen M, Engholm G, et al. Social inequality and incidence of and survival from lung cancer in a population-based study in Denmark, 1994-2003. Eur J Cancer 2008;44:1989-95.
22. Birim O, Kappetein AP, Bogers AJ. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg 2005;28:759-62. (Pubitemid 41539333)
23. Campbell NC, Elliott AM, Sharp L, et al. Rural factors and survival from cancer: analysis of Scottish cancer registrations. Br J Cancer 2000;82:1863-6. (Pubitemid 30307401)
24. Jack RH, Gulliford MC, Ferguson J, et al. Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? Br J Cancer 2003;88:1025-31. (Pubitemid 36560769)
25. Jones AP, Haynes R, Sauerzapf V, et al. Travel times to health care and survival from cancers in Northern England. Eur J Cancer 2008;44:269-74.
26. Stiller CA. Centralised treatment, entry to trials and survival. Br J Cancer 1994;70:352-62. (Pubitemid 24247163)
27. Department of Health. A Policy Framework for Commissioning Cancer Services: a Report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales. London: Department of Health, 1995.
28. Department of Health. The NHS Cancer Plan. London: Department of Health, 2000.
29. Department of Health. Cancer Reform Strategy. London: Department of Health, 2007.
30. Department of Health. Guidance on Commissioning Cancer Services; Improving Outcomes in Lung Cancer: The Manual.London: Department of Health, 1998.